Decision on adjuvant treatment for stage II colon cancers based on analysis of circulating tumor DNA. Options include surgery, surveillance, or adjuvant chemotherapy based on various prognostic factors. Clinical trials are available for tumors with specific mutations. Testing for DPD deficiency before administering certain chemotherapy regimens is recommended. Adjustments to dosages may be necessary based on individual patient factors.